Bajaj Healthcare · NSE: BAJAJHCARE · BSE: 539872
Q1 FY22 results · Apr–Jun 2021
Bajaj Healthcare reported revenue from operations of ₹185.69 crore (up 32.8% from Q1 FY21) and net profit of ₹19.22 crore (up 25.7% from Q1 FY21) for Q1 FY22 (Apr–Jun 2021), on a standalone basis.
| Item | Q1 FY22 | Q1 FY21 | YoY | Q4 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 185.69 | 139.83 | +32.8% | 132.18 | +40.5% |
| Other income | 0.68 | 0.90 | −24.6% | 2.15 | −68.4% |
| Total income | 186.37 | 140.73 | +32.4% | 134.33 | +38.7% |
| Profit before tax | 27.25 | 20.43 | +33.4% | 30.19 | −9.7% |
| Net profit for the period | 19.22 | 15.29 | +25.7% | 21.28 | −9.7% |
| EPS, basic (₹) | 13.93 | 11.08 | +25.7% | 15.42 | −9.7% |
| Net margin (%) | 10.3 | 10.9 | 16.1 |
Standalone
- Filed with BSE
- 03 Aug 2021, 18:20 IST
- Board meeting
- 03 Aug 2021
- Period
- 01 Apr 2021 to 30 Jun 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE